JAMYLENE 50 mg, coated tablet 40 tablets
Active ingredients: Docusate sodium
Commercialized according to BDPM
Coated tablet40 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JAMYLENE 50 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 40 comprimé(s)
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Nov 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68486676CIP73054835CIP133400930548356Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (DOCUSATE DE)comprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.